Home » Newsletters » BioWorld Science

BioWorld Science

March 31, 2022

View Archived Issues

Adenosine A2B receptor targeting protects against acetaminophen-induced hepatotoxicity

New STING agonists identified at The Scripps Research Institute

Orexia Therapeutics discovers orexin OX2 receptor agonists

The University of Southern California patents Huntingtin aggregation inhibitors

New STAT5 inhibitors synthesized at Janpix

New NLRP3 inflammasome inhibitors identified at NodThera

ANDY mouse mimics age-dependent NAD decline and its metabolic impact

Centrin-knockout L. mexicana show immunization promise for New World cutaneous leishmaniasis

AC-0027136 improves memory impairment and mitochondrial function

VYN-201 demonstrates promise in anti-collagen antibody-induced mouse model of RA

SBT-272 shows behavioral and metabolic improvements in mouse model of Huntington's disease

Eloxx expands ELX-02 development program to include Alport syndrome

New cathepsin L inhibitors for the treatment of HCC

Deleting protein switches macrophages to reduced-fat diet

Zelluna collaborates with Etcembly and Nextera to optimize pipeline TCRs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.